Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer

Background: The effect of adjuvant chemotherapy on stage II colon cancer remains constantly controversial. Recently, however, several studies have reported the definite survival benefit of adjuvant chemotherapy (ACT) in T4 disease (stage IIB and IIC) among stage II colon cancer patients. The followi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qi, Luo, Dakui, An, Hongyin, Zhang, Sheng, Cai, Sanjun, Li, Qingguo, Li, Xinxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400679/
https://www.ncbi.nlm.nih.gov/pubmed/30854130
http://dx.doi.org/10.7150/jca.28917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400679/
https://www.ncbi.nlm.nih.gov/pubmed/30854130
http://dx.doi.org/10.7150/jca.28917

Ejemplares similares